SANDOZ DESVENLAFAXINE

Sandoz Canada, Inc.🇨🇦 Health Canada

Approval Id: 16ecbd5637fcdbaa
Drug Approval Canada Name: SANDOZ DESVENLAFAXINE
Product Name: SANDOZ DESVENLAFAXINE
Status: Marketed
Status Date: 2024-05-30
Original Market Date: 2024-05-30
Din: 02538415
Drug Class: Human
Dosage Form: Tablet (Extended-Release)
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 28:16.04.16
Atc Original: N06AX23 DESVENLAFAXINE
Atc Name: n 06 ax 23
Aig Number: 0152509001
Company Name: Sandoz Canada, Inc.
Company Address: 4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path: /organization/sandoz-canada-inc

DESVENLAFAXINE

50 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

16ecbd5637fcdbaa

Type

Standard